Development of a Transcription Factor-Based Prognostic Model for Predicting the Immune Status and Outcome in Pancreatic Adenocarcinoma

<div>Functional analysis based on the dysregulated TFs between the two risk groups in PAAD. (a) Bubble graph for GO enrichment. (b) Bar plot graph for KEGG pathways.</div>

Journal of Immunology Research

fig2

Figure 2

Figure 2: Development of a Transcription Factor-Based Prognostic Model for Predicting the Immune Status and Outcome in Pancreatic Adenocarcinoma 